Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06134323
Status:
RECRUITING
Last Update Posted:
2023-12-20
First Post:
2023-11-12
Brief Title:
Transcutaneous Vagus Nerve Stimulation for Generalized Anxiety Disorder
Sponsor:
Xijing Hospital
Organization:
Xijing Hospital
Study Overview
Official Title:
Efficacy and Mechanism of Transcutaneous Vagus Nerve Stimulation in the Treatment of Generalized Anxiety Disorder
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized double-blind parallel-controlled study of patients with generalized anxiety disorder who will be randomly assigned to either drug-combined transcutaneous vagus nerve stimulation tVNS group or drug-combined sham-stimulation group for a period of 4 weeks of treatmentScale assessments will be performed at baseline week 1 week 2 week 3 and week 4 of treatment and brain function monitoring as well as laboratory tests will be performed at baseline and at the end of treatment respectivelyThe aim of this study is to investigate the efficacy of medication combined with tVNS and the possible mechanisms of tVNS in the treatment of anxiety
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None